EPISTEMOLOGY AND ETHICS OF QUALITY IMPROVEMENT

质量改进的认识论和伦理学

基本信息

批准号：
6460206
负责人：
DORCAS JOANNE LYNN
金额：
$ 5万
依托单位：
RAND CORPORATION
依托单位国家：
美国
项目类别：
财政年份：
2001
资助国家：
美国
起止时间：
2001-07-01 至 2002-06-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/6460206
关键词：
clinical research ethics meeting /conference /symposium

项目摘要

This research conference, to be held December 8-9, 2001, will examine and develop a framework for articulating the epistemology of and ethical dilemmas produced by quality improvement (QI) efforts so as to suggest if current processes and procedures for protecting human research subjects are appropriately applied to QI work. The specific aims are to: 1. Articulate the major arguments about the nature of the knowledge that can be gained from quality improvement efforts and standards for assessing its validity. 2. Examine the potential risks, benefits and harms of QI and determine what levels of benefit are necessary, as well as what levels of risk are acceptable, for the performance of QI work. 3. Identify privacy concerns and informed consent considerations that arise from QI work. 4. Identify priority areas for research on the conceptual, ethical and empirical dimensions of quality improvement especially in areas that have specific importance in the regulation of QI with respect to protection of human subjects. The approximately 30 participants at the invitational conference will include: clinical researchers; health services researchers; researchers in anthropology, qualitative sociology and educational innovation; medical, nursing and allied health professionals engaged in QI; medical administrators with oversight roles in QI projects; risk managers; IRB members; ethicists; patient advocates; and government representatives (e.g. AHRQ). To develop the conference agenda, finalize the list of speakers and outline the conceptual issues to be discussed in the invited papers, a meeting of the planning committee will be held on July 15, 2000 at RAND offices in Arlington, VA. Four papers and a review of the literature will be commissioned for discussion as part of the conference agenda. After the conference, a manuscript synthesizing the conference insights on specific questions and methodological approaches will be prepared by Joanne Lynn, MD, Bruce Jennings, MA, Melissa M. Bottrell, MPH, PhDc, and other members of the planning committee. The manuscript will be submitted to professional journal and be made available on the World Wide Web. At least one presentation will be made at a professional meeting concerned with bioethics and research regulation.

这次研究会议将于 2001 年 12 月 8 日至 9 日举行，将审查并制定一个框架，用于阐明质量改进（QI）工作所产生的认识论和伦理困境，以便建议当前保护人类研究对象的过程和程序是否有效。适当地应用于 QI 工作。具体目标是： 1. 阐明关于可从质量改进工作中获得的知识的性质的主要论点以及评估其有效性的标准。 2. 检查 QI 的潜在风险、收益和危害，并确定执行 QI 工作所需的收益水平以及可接受的风险水平。 3. 确定 QI 工作中出现的隐私问题和知情同意注意事项。 4. 确定质量改进的概念、伦理和实证方面的优先研究领域，特别是在保护人类受试者方面对质量调节具有特殊重要性的领域。邀请会议的约 30 名与会者将包括：临床研究人员；卫生服务研究人员；人类学、定性社会学和教育创新领域的研究人员；从事 QI 的医疗、护理和联合健康专业人员；在 QI 项目中担任监督角色的医疗管理人员；风险经理； IRB 成员；伦理学家；患者权益倡导者；和政府代表（例如 AHRQ）。为了制定会议议程、最终确定发言者名单并概述受邀论文中要讨论的概念性问题，计划委员会会议将于 2000 年 7 月 15 日在弗吉尼亚州阿灵顿的兰德办事处举行。作为会议议程的一部分，将委托讨论四篇论文和一篇文献综述。会议结束后，Joanne Lynn（医学博士）、Bruce Jennings（文学硕士）、Melissa M. Bottrell（公共卫生硕士、博士）和规划委员会的其他成员将编写一份手稿，综合会议对具体问题和方法论的见解。稿件将提交给专业期刊并在万维网上发布。至少将在有关生物伦理学和研究监管的专业会议上进行一次演讲。